Vishwas Seshadri Abeona Therapeutics Inc. (ABEO) insider trading activity

Vishwas Seshadri is Chief Executive Officer of ABEONA THERAPEUTICS INC.. Currently has a direct ownership of 1.23 Million shares of ABEO, which is worth approximately $7.21 Million. The most recent transaction as insider was on Jul 09, 2025, when has been sold 69,420 shares (Common Stock) at a price of $5.86 per share, resulting in proceeds of $406,801. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.23M

8.93% 3M change

33.74% 12M change

Total Value Held $7.21 Million

Vishwas Seshadri Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 09 2025	SELL Open market or private sale	$406,801 $5.86 p/Share	69,420 Reduced 5.32%	1,234,341 Common Stock
Jun 06 2025	SELL Open market or private sale	$342,569 $6.76 p/Share	50,676 Reduced 3.74%	1,303,761 Common Stock
Jun 01 2025	SELL Payment of exercise price or tax liability	$5,522 $6.24 p/Share	885 Reduced 0.07%	1,354,437 Common Stock
Mar 31 2025	SELL Open market or private sale	$119,500 $4.78 p/Share	25,000 Reduced 1.81%	1,355,322 Common Stock
Jan 21 2025	BUY Grant, award, or other acquisition	-	476,435 Added 25.66%	1,380,322 Common Stock
Oct 16 2024	SELL Payment of exercise price or tax liability	$1,641 $6.54 p/Share	251 Reduced 0.03%	903,887 Common Stock
Sep 28 2024	SELL Payment of exercise price or tax liability	$110,720 $5.89 p/Share	18,798 Reduced 2.04%	904,138 Common Stock
Jul 08 2024	BUY Grant, award, or other acquisition	-	424,000 Added 31.48%	922,936 Common Stock
Jun 05 2024	SELL Payment of exercise price or tax liability	$174,566 $4.52 p/Share	38,621 Reduced 7.18%	498,936 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$3,079 $4.38 p/Share	703 Reduced 0.13%	537,557 Common Stock
Apr 25 2024	BUY Open market or private purchase	$32,000 $3.2 p/Share	10,000 Added 1.82%	538,260 Common Stock
Feb 06 2024	BUY Open market or private purchase	$87,800 $4.39 p/Share	20,000 Added 3.65%	528,260 Common Stock
Oct 16 2023	SELL Payment of exercise price or tax liability	$749 $4.14 p/Share	181 Reduced 0.04%	508,260 Common Stock
Sep 29 2023	SELL Payment of exercise price or tax liability	$52,229 $3.93 p/Share	13,290 Reduced 2.55%	508,441 Common Stock
Sep 27 2023	BUY Open market or private purchase	$81,400 $4.07 p/Share	20,000 Added 3.69%	521,731 Common Stock
Jun 05 2023	BUY Grant, award, or other acquisition	-	336,826 Added 40.17%	501,731 Common Stock
Jun 02 2023	SELL Payment of exercise price or tax liability	$2,530 $3.06 p/Share	827 Reduced 0.5%	164,905 Common Stock
Oct 17 2022	SELL Payment of exercise price or tax liability	$890 $4.3 p/Share	207 Reduced 0.12%	165,732 Common Stock
Sep 28 2022	BUY Grant, award, or other acquisition	-	155,200 Added 48.33%	165,939 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$13,044 $0.16 p/Share	81,525 Reduced 23.29%	268,475 Common Stock
Oct 15 2021	BUY Grant, award, or other acquisition	-	50,000 Added 12.5%	350,000 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	300,000 Added 50.0%	300,000 Common Stock

Vishwas Seshadri

Chief Executive Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABEO shares.

Notify only if

Value

Insider Trading

Get notified when an Abeona Therapeutics Inc. insider buys or sells ABEO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ABEONA THERAPEUTICS INC.

Track Activities on ABEO

Account